A new study has identified 71 new genetic associations for inflammatory bowel disease (IBD), many of which have been previously linked to other immune-related disorders.

Researchers observed a striking overlap between the genetics predisposing a person to IBD and their body’s ability to respond to mycobacterial infection, the organism that causes tuberculosis.

This gene discovery offers an opportunity to begin identifying new targets for treatment, better diagnostic tools and improved long-term, personalised care for patients.